Updated Anaphylaxis Guidance: A Crucial Shift for First Responders

First Aiders across the UK and Ireland are urged to familiarise themselves with recent updates to anaphylaxis management guidelines, which place a renewed emphasis on the rapid administration of adrenaline via auto-injector. These revisions, driven by insights from bodies such as the Resuscitation Council UK (RCUK) and the British Society for Allergy & Clinical Immunology (BSACI), underscore the critical importance of immediate intervention in life-threatening allergic reactions.

Anaphylaxis remains a significant public health concern. The National Anaphylaxis Centre estimates that severe allergic reactions affect up to 1 in 100 people in the UK. While fatalities are rare, prompt and correct first aid is paramount to preventing tragic outcomes. The updated guidance aims to streamline the response, empowering First Aiders with clear, actionable steps.

Key Changes and Emphasis on Early Adrenaline

The most significant shift in the updated guidelines revolves around the timing of adrenaline auto-injector (AAI) administration. Previous guidance often involved a more cautious approach, sometimes leading to delays as First Aiders sought confirmation of symptoms or waited for medical professionals. The new consensus strongly advocates for earlier use of adrenaline when anaphylaxis is suspected.

  • Prompt Administration: If an individual presents with signs of a severe allergic reaction (e.g., sudden onset of severe breathing difficulties, collapse, or a rapid progression of skin/mucosal changes with cardiovascular or respiratory compromise), adrenaline should be administered without delay.
  • Recognising Symptoms: First Aiders are reminded to recognise the typical signs of anaphylaxis, which can include:
    • Skin changes: Hives, flushing, swelling (angioedema).
    • Respiratory symptoms: Difficulty breathing, wheezing, persistent cough, hoarse voice.
    • Gastrointestinal symptoms: Abdominal pain, vomiting, diarrhoea.
    • Cardiovascular symptoms: Dizziness, faintness, collapse, pallor.
  • No Delay for Confirmation: The guidance clarifies that if anaphylaxis is strongly suspected, the benefits of early adrenaline outweigh the risks of administering it unnecessarily. Waiting for paramedics can lead to a critical delay in treatment.
  • Second Dose Consideration: If there is no improvement or symptoms worsen after 5-10 minutes following the first dose of adrenaline, a second dose should be considered if available, while awaiting emergency medical services.

These recommendations align with international best practices and reflect a growing understanding of the pathophysiology of anaphylaxis, where early intervention with adrenaline can halt the progression of the reaction and prevent circulatory collapse.

Implications for First Aid Training and Workplace Safety

The updated guidelines have direct implications for first aid training providers and employers responsible for workplace safety. The Health and Safety Executive (HSE) in the UK and the Health and Safety Authority (HSA) in Ireland both mandate that first aid provision in the workplace is adequate and appropriate for the risks identified.

Related training: If you are looking to qualify as a trainer in this area, see child protection trainer qualifications or explore safe people handling trainer courses for nationally recognised UK and Ireland qualifications.

First aid training courses, particularly those covering emergency first aid at work (EFAW) and first aid at work (FAW), will need to integrate these revised protocols. Trainers must ensure that participants are confident in recognising anaphylaxis and proficient in the correct use of various adrenaline auto-injector devices (e.g., EpiPen, Jext, Emerade).

Employers should review their first aid needs assessments to ensure that:

  • First Aiders receive up-to-date training on anaphylaxis management.
  • Workplaces with employees or visitors known to be at risk of anaphylaxis have access to appropriate first aid equipment, including potentially designated adrenaline auto-injectors, where allowed by specific regulations (e.g., in schools under the Human Medicines (Amendment) Regulations 2017 in England).
  • Clear emergency plans are in place for responding to anaphylactic reactions, including calling emergency services (999 or 112) immediately after administering adrenaline.

The RCUK's 2021 guidelines for anaphylaxis management explicitly state, "Adrenaline is the first-line treatment for anaphylaxis and should be given without delay." This clear directive reinforces the proactive approach now expected from First Aiders. The importance of positioning the casualty correctly – lying flat with legs raised unless breathing is difficult (then sitting up) or unconscious (recovery position) – also remains a critical component of post-adrenaline care.

Staying current with first aid best practices is not just a regulatory requirement; it is a moral imperative. The ability of a First Aider to confidently and correctly manage an anaphylactic reaction can be the difference between a full recovery and a life-threatening emergency. For comprehensive and up-to-date first aid training, including the latest guidance on anaphylaxis, consider courses offered by Abertay Training at https://www.abertaytraining.co.uk.